The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Diagnostic Approach to Abnormal Liver Function Tests in Asymptomatic Patients

무증상 간기능 검사 이상 환자의 진단적 접근

  • Ahn, Sun-Young (Department of Internal Medicine, Kyungpook National University School of Medicine) ;
  • Park, Soo-Young (Department of Internal Medicine, Kyungpook National University School of Medicine)
  • 안선영 (경북대학교 의학전문대학원 내과학교실) ;
  • 박수영 (경북대학교 의학전문대학원 내과학교실)
  • Published : 2012.02.01
⟨ Previous Next ⟩

Abstract

Interpretation of abnormalities in liver function tests is valuable because they provide clues for various hepatobiliary disease. Because liver function tests have become a routine checkup in screening tests, isolated alterations of biochemical markers of liver damage in a seemingly healthy patient often represent a challenge for a clinician. Detailed history taking and physical examination are often helpful in interpretation of abnormal liver function tests and differential diagnosis. Proper diagnosis and management can be made with further laboratory tests and understanding of the laboratory results.

Keywords

References

  1. Pratt DS, Kaplan MM. Evaluation of abnormal liverenzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-1271. https://doi.org/10.1056/NEJM200004273421707
  2. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367-1384. https://doi.org/10.1053/gast.2002.36061
  3. Hultcrantz R, Glaumann H, Lindberg G, Nilsson LH. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scand J Gastroenterol 1986;21:109-113.
  4. Kundrotas LW, Clement DJ. Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors. Dig Dis Sci 1993;38:2145-2150. https://doi.org/10.1007/BF01299887
  5. Minuk GY. Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests. Can J Gastroenterol 1998;12:417-421. https://doi.org/10.1155/1998/943498
  6. Piton A, Poynard T, Imbert-Bismut F, et al. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C: MULTIVIRC Group. Hepatology 1998;27:1213-1219. https://doi.org/10.1002/hep.510270505
  7. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999;45:129-133. https://doi.org/10.1136/gut.45.1.129
  8. Giannini E, Risso D, Botta F, et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163:218-224. https://doi.org/10.1001/archinte.163.2.218
  9. Katkov WN, Friedman LS, Cody H, et al. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med 1991;115:882-884. https://doi.org/10.7326/0003-4819-115-11-882
  10. Cohen JA, Kaplan MM. The SGOT/SGPT ratio: an indicator of alcoholic liver disease. Dig Dis Sci 1979;24:835-838. https://doi.org/10.1007/BF01324898
  11. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-636.
  12. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury: I. performance characteristics of laboratory tests. Clin Chem 2000;46:2027-2049.
  13. Fogden E, Neuberger J. Alternative medicines and the liver. Liver Int 2003;23:213-220 https://doi.org/10.1034/j.1600-0676.2003.00843.x
  14. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-485. https://doi.org/10.1056/NEJMra021844
  15. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109. https://doi.org/10.1016/0016-5085(94)90235-6
  16. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics: a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-1062. https://doi.org/10.1016/0016-5085(88)90183-7
  17. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986;220:83-88.
  18. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419. https://doi.org/10.1016/S0016-5085(99)70506-8
  19. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34:255-262. https://doi.org/10.1097/00004836-200203000-00013
  20. Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984;4:1-12. https://doi.org/10.1055/s-2008-1040641
  21. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334:897-903. https://doi.org/10.1056/NEJM199604043341406
  22. Tavill AS; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-1328. https://doi.org/10.1053/jhep.2001.24783
  23. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998;129: 925-931. https://doi.org/10.7326/0003-4819-129-11_Part_2-199812011-00002
  24. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-142. https://doi.org/10.1034/j.1600-0676.2003.00824.x
  25. Roberts EA, Schilsky ML; Division of Gastroenterology and Nutrition, Hospital for Sick Children, Toronto, Ontario, Canada. A practice guideline on Wilson disease. Hepatology 2003;37:1475-1492. https://doi.org/10.1053/jhep.2003.50252
  26. Daniel S, Ben-Menachem T, Vasudevan G, Ma CK, Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999;94: 3010-3014. https://doi.org/10.1111/j.1572-0241.1999.01451.x
  27. Wolf PL. Clinical significance of an increased or decreased serum alkaline phosphatase level. Arch Pathol Lab Med 1978;102:497-501.
  28. Goldberg DM, Martin JV. Role of gamma-glutamyl transpeptidase activity in the diagnosis of hepatobiliary disease. Digestion 1975;12:232-246. https://doi.org/10.1159/000197682
  29. Moussavian SN, Becker RC, Piepmeyer JL, Mezey E, Bozian RC. Serum gamma-glutamyl transpeptidase and chronic alcoholism: influence of alcohol ingestion and liver disease. Dig Dis Sci 1985;30:211-214. https://doi.org/10.1007/BF01347885
  30. Orrego H, Blake JE, Israel Y. Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcohol Clin Exp Res 1985;9:10-13. https://doi.org/10.1111/j.1530-0277.1985.tb05038.x
  31. Rosalki SB, Tarlow D, Rau D. Plasma gamma-glutamyl transpeptidase elevation in patients receiving enzymeinducing drugs. Lancet 1971;2:376-377.
  32. Berk PD. Bilirubin metabolism and the hereditary hyperbilirubinemias. Semin Liver Dis 1994;14:321-322. https://doi.org/10.1055/s-2007-1007321
  33. Anciaux ML, Pelletier G, Attali P, Meduri B, Liguory C, Etienne JP. Prospective study of clinical and biochemical features of symptomatic choledocholithiasis. Dig Dis Sci 1986;31:449-453. https://doi.org/10.1007/BF01320306

Cited by

  1. 산화스트레스가 유도된 HepG2 세포에서 Eriodictyol의 항산화 효과 vol.45, pp.4, 2016, https://doi.org/10.3746/jkfn.2016.45.4.510
  2. 제조방법을 달리한 경옥고의 고콜레스테롤혈증 흰쥐에 미치는 효능 비교 연구 vol.32, pp.3, 2017, https://doi.org/10.6116/kjh.2017.32.3.9